Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1826]
News [2739]
Articles [202]
Editorials [1]
Conferences [136]
elearning [13]
Engineering of polymeric nanoparticles for medical applications
Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013
ecancerNews November Round Up
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancerNews November Round Up ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
14 Nov 2013
Editor’s Choice - ecancermedicalscience November 2013
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Editor’s Choice - ecancermedicalscience November 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
14 Nov 2013
The future of CLL treatment: balancing efficacy, safety and cost
Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA
The future of CLL treatment: balancing efficacy, safety and cost ( Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA )
14 Nov 2013
Making sense of the expanding armoury of treatment options for the less fit CLL...
Dr Valentin Goede - Uniklinik Köln, Cologne, Germany
Making sense of the expanding armoury of treatment options for the less fit CLL patient ( Dr Valentin Goede - Uniklinik Köln, Cologne, Germany )
14 Nov 2013
‘Go-Go’ CLL patients: a look towards the future
Professor Clemens Wendtner - Klinikum Schwabing, Munich, Germany
‘Go-Go’ CLL patients: a look towards the future ( Professor Clemens Wendtner - Klinikum Schwabing, Munich, Germany )
14 Nov 2013
The aTTom study: randomised comparison of continuing adjuvant in ER positive or...
Dr Daniel Rea - University of Birmingham, UK
The aTTom study: randomised comparison of continuing adjuvant in ER positive or ER untested early breast cancer ( Dr Daniel Rea - University of Birmingham, UK )
12 Nov 2013
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer
Dr Chris Gallagher - Barts and the London NHS Trust, UK
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer ( Dr Chris Gallagher - Barts and the London NHS Trust, UK )
12 Nov 2013
Chemosaturation therapy for cancers in the liver
Dr Stephen Fenwick - Aintree University Hospital, Liverpool, UK
Chemosaturation therapy for cancers in the liver ( Dr Stephen Fenwick - Aintree University Hospital, Liverpool, UK )
11 Nov 2013
The role of molecular pathways in therapeutic response and outcomes in breast...
Dr Fabrice André - Institut Gustave Roussy, Villejuif, France
The role of molecular pathways in therapeutic response and outcomes in breast cancer ( Dr Fabrice André - Institut Gustave Roussy, Villejuif, France )
8 Nov 2013
Traditional and personalised models of therapy in gastrointestinal and...
Dr Jaume Capdevila - Vall d'Hebron University Hospita, Barcelona, Spain
Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers ( Dr Jaume Capdevila - Vall d'Hebron University Hospita, Barcelona, Spain )
8 Nov 2013
Future perspectives: realising the potential of personalised healthcare in...
Dr Jonathan Ledermann - University College London, United Kingdom
Future perspectives: realising the potential of personalised healthcare in gynaecological cancer ( Dr Jonathan Ledermann - University College London, United Kingdom )
8 Nov 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation